Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Kaley D"'
Publikováno v:
In Advanced Drug Delivery Reviews 2009 61(3):233-242
Autor:
Wilson, Kaley D., Raney, Sameersingh G., Sekirov, Laura, Chikh, Ghania, deJong, Susan D., Cullis, Pieter R., Tam, Ying K.
Publikováno v:
In International Immunopharmacology 2007 7(8):1064-1075
Autor:
Van Brunt, K., Gwaltney, C., Kaley, D., Krupnick, R., Phinney, M., Bailey, E., Bresnick, K., Booth, J.
Publikováno v:
In Journal of Cystic Fibrosis November 2021 20 Supplement 2:S137-S138
Autor:
Raney, Sameersingh G.1 (AUTHOR), Wilson, Kaley D.1,2 (AUTHOR) kaley@interchange.ubc.ca, Sekirov, Laura1 (AUTHOR), Chikh, Ghania1 (AUTHOR), de Jong, Susan D.2 (AUTHOR), Cullis, Pieter R.2 (AUTHOR), Tam, Ying K.1 (AUTHOR)
Publikováno v:
Journal of Drug Targeting. Aug2008, Vol. 16 Issue 7/8, p564-577. 14p. 8 Graphs.
Publikováno v:
Cancer Research. 72:P4-13
BACKGROUND. Estrogen [E] for women entering menopause is not perceived beneficial for either iBrCa or CHD. However, data from RCTs suggest that use of Estrogen reduces: a. rates of invasive breast cancer [iBrCa], andb. atherogenesis, vessel pathology
Publikováno v:
Cancer Research. 70:P6-09
Introduction Until the randomized Women Healths Initiative [WHI] trials 1,2, most hormone replacement therapy (HRT) studies showed an association of HRT with higher BrCa risk. However, our recent reviews of the WHI trials suggested that Estrogen alon
Synthetic methylated CpG ODNs are potent in vivo adjuvants when delivered in liposomal nanoparticles
Autor:
Susan D. de Jong, Pieter R. Cullis, Sameersingh G. Raney, Laura Sekirov, Jan P. Dutz, Ghania Chikh, Mikameh Kazem, Ying K. Tam, Kaley D. Wilson
Publikováno v:
International Immunology. 21:757-767
Although it is well documented that the immunological activity of cytosine-guanine (CpG) motifs is abrogated by 5' methylation of the cytosine residue, encapsulation within stabilized lipid nanoparticles endows these methylated cytosine-guanine- (mCp
Autor:
Ying K. Tam, Kaley D. Wilson
Publikováno v:
Expert review of clinical pharmacology. 2(2)
The anti-tumor activity of CpG-containing oligodeoxynucleotides (ODNs) has been well established in numerous animal models and confirmed in a number of early clinical trials. While the use of chemical modifications has effectively reduced the sensiti
Autor:
Pieter R. Cullis, Ying Tam, Mikameh Kazem, Susan D. de Jong, Wilf Jefferies, Genc Basha, Kaley D. Wilson
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 184(11)
TLR9 recognizes CpG motifs present in pathogenic DNA and triggers potent immune responses. It is generally accepted that TLR9 distinguishes pathogenic DNA based, in part, on methylation status, where TLR9 binds unmethylated but not methylated CpG. Ho
Autor:
Pieter R. Cullis, Ying K. Tam, Kaley D. Wilson, Michael J. Hope, Susan D. de Jong, Mikameh Kazem, Ryan Lall
Publikováno v:
The journal of gene medicine. 11(1)
Background DNA vaccines offer unique potential for generating protective and therapeutic immunity against infectious and malignant diseases. Unfortunately, rapid degradation and poor cellular uptake has significantly limited the efficacy of ‘naked